Lonidamine plus epirubicin and cyclophosphamide in advanced breast cancer. A phase II study

Eur J Cancer. 1996 Jan;32A(1):176-7. doi: 10.1016/0959-8049(95)00466-1.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Cyclophosphamide / administration & dosage
  • Epirubicin / administration & dosage
  • Female
  • Humans
  • Indazoles / administration & dosage
  • Middle Aged

Substances

  • Indazoles
  • Epirubicin
  • Cyclophosphamide
  • lonidamine